Gracias por la invitación!

New study from Global PBC highlights the importance of longitudinal FibroScan measurements in assessing liver prognosis! Regular monitoring can lead to better outcomes and individualized treatment plans. #LiverHealth #FibroScan cghjournal.org/article/S1542-…

PBC Foundation and friends in Brussels. Patients rally against EU ban on autoimmune drug. euronews.com/health/2024/07… #PBC #SupportForLife

🎉 Happy World Hepatitis Day! 🌍 Let's come together to raise awareness about viral hepatitis and encourage those who may be at risk to get tested and treated. Knowledge is power, and early detection can save lives. #WorldHepatitisDay #KnowHepatitis #TestTreat

Excited to share our new paper on the importance of validating prognostic scores for PBC (primary biliary cholangitis) prognosis! Proper validation is crucial to ensure accurate prediction of UDCA (ursodeoxycholic acid) response in a clinical setting. #PBC #prognosis

Excited to share the amazing work being done by our autoimmune disease research team! Their dedication and innovative thinking are truly making a difference in the lives of those affected. #AutoimmuneAwareness

Excited and honored to have abstracts accepted for presentation at the AASLD conference! Can't wait to share our research and learn from other leaders in the field of liver disease. #AASLD2022 #LiverDiseaseResearch

Join us tomorrow at 8 pm Boston time to discuss the management and diagnosis of metabolic liver disease in patients with Diabetes Mellitus! Thank you to the Endocrinology Association of the Dominican Republic for hosting. #liverdisease #masld

Exciting news to share from BIDMC! Our team successfully performed the first laparoscopic donor surgery, marking a major step forward for our Living Donor Transplant Program. We are so proud of our dedicated team for their hard work and commitment to improving the lives of our

Excited to be in Chile for the ALEH conference and share the latest on Primary Biliary Cholangitis! See you there! #PBCholangitis #ALEH2023

Exciting news for PBC patients! The FDA has approved Livdelzi (seladelpar) – a significant advancement in therapy options. It's incredible to see the progress being made in the treatment of this rare disease. #PBC #Livdelzi #FDAapproval

Within 750 miles of Boston, BIDMC Liver Transplant is the only 13-bar program out of 47 transplant centers. Waitlist mortality is an issue. BIDMC is proud to transplant patients on average within 30 days from listing. Come see us for a consultation if you've been waiting.

Why wait for a liver transplant? Come to @BIDMC to access one of the most comprehensive liver centers in the country. Our team of experts is here to provide exceptional care, every step of the way. #LiverTransplant #BIDMC

Can't contain my excitement for PBC (Primary Biliary Cholangitis) Day and the upcoming PBC conference! Get ready for a 2 days with valuable learning and networking opportunities with fellow patients. Let's come together to raise awareness, share our experiences, and support each

Exciting news! Elafibranor is now available for the treatment of non-responding #PBC patients. Our latest review of the data from the New England Journal of Medicine highlights the significant potential of this PPAR agonist ⁦Daniela Goyes, MD⁩ practiceupdate.com/content/effica…

🎉 Happy PBC Day! Today, let's spread awareness about this often-overlooked autoimmune liver disease. Exciting advances in treatments are helping us better manage PBC and improve patients' lives. Together, we can make a difference! #PBCDay #AutoimmuneLiverDisease #Awareness

Grateful to ALEH and Intercept for the wonderful invitation to Chile! It was an honor to share research and learn from others. Looking forward to seeing everyone in Lima next year for another great conference. #ALEH #liverdisease

Just released: Our latest article reveals that patients with both MASLD and AIH face higher liver transplant rates. This important finding highlights the urgent need for improved treatment options and monitoring onlinelibrary.wiley.com/doi/epdf/10.11…